Hind Harrak, PhD

Sr. Manager, Pharmacoepidemiology
Regeneron Pharmaceuticals

Poster(s):

• (299) Assessing the agreement between open and closed medical claims in a rare disease cohort
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (BSPOT38) Estimating period prevalence: comparing methods to describe a rare disease population
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST